Ceftizoxime--antibacterial activity, pharmacokinetic properties, clinical application
Iakovlev, V.P.
Antibiotiki i Khimioterapiia 39(6): 49-62
1994
ISSN/ISBN: 0235-2990 PMID: 7848008 Document Number: 434598
Document emailed within 1 workday
Related Documents
Motohiro, T.; Sakata, Y.; Tominaga, K.; Oda, K.; Aramaki, M.; Tanaka, K.; Kawakami, A.; Shimada, Y.; Koga, T.; Tomita, S. 1988: Pharmacokinetic, bacteriological and clinical studies of ceftizoxime in neonates and low birth weight infants Japanese Journal of Antibiotics 41(8): 1116-1128Naumann, P. 1975: Cephalosporin antibiotics from microbiologic viewpoint. A comparison of antibacterial and pharmacokinetic properties International Journal of Clinical Pharmacology and Biopharmacy 11(2): 85-92
Xerri, L.; Broggio, R. 1985: Study on the antibacterial activity of ceftazidime in an in vitro pharmacokinetic model Drugs under Experimental and Clinical Research 11(1): 49-54
Geelen, S.P.; Roord, J.J.; Neeleman, C.; Fleer, A. 1987: Cephalosporins: microbiological and pharmacokinetic properties, application to pediatrics Tijdschrift Voor Kindergeneeskunde 55(3): 81-86
Okamoto, Y.; Maehara, K.; Ueda, Y.; Nasu, M.; Kamiki, T.; Iri, H.; Nagai, T.; Kumamoto, Y.; Sakai, S.; Shigeta, S.; Kosaki, N.; Oguri, T. 1981: Comparison of antibacterial activity of oral antibacterial agents against recently isolated bacteria of E. coli, Klebsiella, Citrobacter and Proteus from clinical materials of urinary tract infection Japanese Journal of Antibiotics 34(6): 959-975
Igari, J.; Watanabe, N.; Uehara, N.; Inoue, M.; Yoshida, H.; Imafuku, Y.; Nishino, T.; Shibano, T.; Satou, S.; Kobayashi, I.; Takahashi, A.; Yomoda, S.; Matsuoka, K.; Oguri, T.; Ohba, Y.; Kumasaka, K.; Tokuda, K.; Kobayashi, Y.; Hongo, T.; Okada, J.; Sasaki, T.; Matsumoto, N.; Hirata, Y.; Nakasaki, N.; Ono, J.; Takata, T.; Kawaguchi, R.; Ohtaki, Y.; Kajimura, K.; Ishigo, S.; Hashimoto, T.; Aoki, N.; Okamoto, E.; Murakami, E.; Saeki, H. 2000: Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents Japanese Journal of Antibiotics 53(3): 157-170
Guggenbichler, J.P.; Trawöger, R. 1991: Therapy of severe bacterial infections in premature and newborn infants and children with ceftizoxime: a pharmacokinetic and therapeutic study Journal of ChemoTherapy 3(Suppl): 20-24
Walczak, M.Z. 2013: Physicochemical profiling of new aminopropan-2-ol derivatives with beta-adrenolytic activity: the importance for pharmacokinetic properties Die Pharmazie 68(11): 866-871
Reeves, D.S.; Bywater, M.J.; Holt, H.A.; Broughall, J.M. 1979: Azlocillin and mezlocillin: laboratory studies of their properties, including comparison with the antibacterial activity of other antibiotics Arzneimittel-Forschung 29(12a): 1920-1929
Kochsiek, K. 1982: Clinical consequences of pharmacokinetic properties of cardiac glycosides European Heart Journal 3 Suppl D: 79-86
Brogden, R.N.; Buckley, M.M.; Ward, A. 1990: Buserelin. a review of its pharmacodynamic and pharmacokinetic properties, and clinical profile Drugs 39(3): 399-437
Tromm, A.; Griga, T.; May, B. 1999: Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties Hepato-Gastroenterology 46(30): 3124-3135
Kumar, M.K.; Jayasagar, G.; Chandrasekhar, K.; Ashok, T.; Rao, Y.M. 2003: Validated HPLC method for the determination of ranitidine in human serum and its application in a clinical pharmacokinetic study Die Pharmazie 58(4): 284-285
Milata, V. 2000: Chemical structure of quinolones and their antibacterial activity. II. 4-quinolones: their occurrence in nature and biological properties Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 49(2): 68-74
Brzezińska, E.; Stańczak, A.; Ochocki, Z. 2003: Structure and biological activity of some 4-amino-3-cinnolinecarboxylic acid derivatives. QSAR analysis of cinnoline derivatives with antibacterial properties Acta Poloniae Pharmaceutica 60(1): 15-20
Potti, G.R.; Kurup, P.A. 1970: Antibacterial principle of the root bark of Calophyllum inophyllum: isolation and antibacterial activity Indian Journal of Experimental Biology 8(1): 39-40
She, W.-j.; Zhang, F.-q. 2003: Comparison of the antibacterial activity on oral pathogens among six types of nano-silver base inorganic antibacterial agents Shanghai Kou Qiang Yi Xue 12(5): 356-358
Brogard, J.M.; Kuntzmann, F.; Lavillaureix, J. 1974: Antibacterial activity, pharmacokinetics and clinical use of a new cephalosporin antibiotic cephacetrile Arzneimittel-Forschung 24(9b): 1528-1533
Guo, H.Y.; Sun, L.Y.; Tang, Y.; Yan, G.H.; Zhang, Z.P. 1988: Studies on pyridonecarboxylic acids as antibacterial agents. VI. Synthesis and antibacterial activity of 7-chloro-6-fluoro-1-ethyt-1, 4-dihydro-4-oxopyrido(2,3-c)pyridazine-3-carboxylic acid and derivatives Yao Xue Xue Bao 23(8): 566-573
Odelola, H.A.; Jaiyebo, O.; Anukam, P.A.; Akanni, A.O. 1989: Comparative in-vitro antibacterial activity of two brands of antibiotics against clinical isolates of some bacterial genera African Journal of Medicine and Medical Sciences 18(4): 307-310